Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
PUT
Teradyne
TER
$65.5B
| $1.59M | ﹤0.01% |
37,900
-76,900
| -67% | -$3.17M |
|
3802
Sea Limited
SE
$74.7B
| $1.58M | ﹤0.01% |
+118,915
| New | +$1.63M |
|
3803
National Fuel Gas
NFG
$7.79B
| $1.58M | ﹤0.01% |
28,824
-23,354
| -45% | -$1.33M |
|
3804
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $1.58M | ﹤0.01% |
27,774
-5,195
| -16% | -$285K |
|
3805
ICICI Bank
IBN
$107B
| $1.58M | ﹤0.01% |
162,059
+83,482
| +106% | +$769K |
|
|
UN
3806
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $1.58M | ﹤0.01% |
28,000
-3,600
| -11% | -$207K |
|
3807
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.66B
| $1.57M | ﹤0.01% |
+53,792
| New | +$1.55M |
|
|
LION
3808
DELISTED
Fidelity Southern Corporation
LION
| $1.57M | ﹤0.01% |
72,082
+9,540
| +15% | +$211K |
|
3809
CALL
Canadian Imperial Bank of Commerce
CM
$113B
| $1.57M | ﹤0.01% |
32,200
+19,600
| +156% | +$892K |
|
3810
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.01B
| $1.57M | ﹤0.01% |
+109,610
| New | +$1.56M |
|
|
NVRO
3811
PUT
DELISTED
NEVRO CORP.
NVRO
| $1.57M | ﹤0.01% |
22,700
-7,900
| -26% | -$632K |
|
3812
US Physical Therapy
USPH
$1.21B
| $1.57M | ﹤0.01% |
21,689
-8,048
| -27% | -$549K |
|
3813
Cracker Barrel
CBRL
$1.29B
| $1.56M | ﹤0.01% |
9,845
-34,382
| -78% | -$5.4M |
|
3814
ITT
ITT
$19.6B
| $1.56M | ﹤0.01% |
29,323
-83,048
| -74% | -$4.17M |
|
3815
VanEck Natural Resources ETF
HAP
$309M
| $1.56M | ﹤0.01% |
+42,105
| New | +$1.52M |
|
3816
Davis Select Financial ETF
DFNL
$497M
| $1.56M | ﹤0.01% |
+65,192
| New | +$1.52M |
|
3817
Global X Uranium ETF
URA
$6.27B
| $1.56M | ﹤0.01% |
103,664
+57,824
| +126% | +$804K |
|
|
ABB
3818
DELISTED
ABB Ltd
ABB
| $1.56M | ﹤0.01% |
58,145
+22,372
| +63% | +$575K |
|
3819
Invesco S&P Spin-Off ETF
CSD
$237M
| $1.56M | ﹤0.01% |
+29,890
| New | +$1.54M |
|
3820
PUT
Molina Healthcare
MOH
$11.1B
| $1.56M | ﹤0.01% |
20,300
+10,100
| +99% | +$729K |
|
3821
TriNet
TNET
$3.16B
| $1.56M | ﹤0.01% |
35,089
+3,431
| +11% | +$137K |
|
|
TRTN
3822
CALL
DELISTED
Triton International Limited
TRTN
| $1.55M | ﹤0.01% |
41,500
+23,000
| +124% | +$884K |
|
3823
PUT
Sanofi
SNY
$105B
| $1.55M | ﹤0.01% |
36,100
+18,100
| +101% | +$835K |
|
3824
CALL
Dana Inc
DAN
$3.26B
| $1.55M | ﹤0.01% |
48,400
+21,200
| +78% | +$652K |
|
3825
Global X Social Media ETF
SOCL
$92.9M
| $1.55M | ﹤0.01% |
47,017
-52,278
| -53% | -$1.72M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.